Comparison of China's and the European Union's Approaches to Antimicrobial Stewardship in the Pork Industry

被引:10
作者
Lim, May Sie Megha [1 ]
Grohn, Yrjo T. [2 ]
机构
[1] Univ Sydney, Sch Vet Sci, Sydney, NSW 2006, Australia
[2] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA
关键词
antimicrobial stewardship; China; European Union; pork; swine; pig; antibiotics; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; ANIMAL HEALTH; FOOD ANIMALS; SALMONELLA; KNOWLEDGE; CRISIS; AGENTS; USAGE; RISK;
D O I
10.1089/fpd.2020.2887
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Antimicrobial resistance (AMR) is a recognized global public health concern. Although the link between antimicrobial usage in food animals and AMR in humans is established, the detailed interactions are unclear. Antimicrobial stewardship (AMS) in livestock was first implemented in Europe with Sweden as the pioneer in 1986. Despite this head start, AMR is still an ongoing challenge for Europe. The European Union (EU) is an established agriculture producer, the second largest pork producer globally, and one of the largest markets for organic food. China is the global leader in both production and consumption of pork. China's rise in prosperity has led to an increase in its pork demand. Chinese producers commonly use antimicrobials during production for disease treatment and prevention to meet this increased demand. China's rising prosperity together with recent publicized food safety scandals, disease outbreaks in domestic livestock products, and increased AMR awareness have resulted in an increased willingness to pay and demand for organic food by Chinese consumers. Responding to the growing concerns of AMR by consumers and the World Health Organization (WHO), the Chinese government introduced a national pilot program in 2016 to reduce unnecessary antimicrobial use. Compared with China, the EU is a different entity as it is a political union comprising diverse countries and although it may have more experience in AMS, both entities face similar issues with AMR and increasing demand for organic food. Increased interest in organic food has arisen due to concerns about AMR, food safety, outbreaks of bacterial food contamination, and animal welfare. This article aims to compare the different AMS strategies employed by each entity, China and the EU, and how the increased demand for organic produce globally also influences the effort to reduce antimicrobial use in these entities' pork industries.
引用
收藏
页码:567 / 573
页数:7
相关论文
共 72 条
[1]   Get pigs off antibiotics [J].
Aarestrup, Frank .
NATURE, 2012, 486 (7404) :465-466
[2]  
Aidara-Kane A, 2012, REV SCI TECH OIE, V31, P277
[3]   Putting vets on shortage occupation list [J].
不详 .
VETERINARY RECORD, 2017, 181 (19) :496-496
[4]  
[Anonymous], 2019, Tackling Antimicrobial Use and Resistance in Pig Production: Lessons Learned in Denmark, DOI DOI 10.18356/9D63B715-EN
[5]  
[Anonymous], 2020, China Daily
[6]   Close to a Decade of Decrease in Antimicrobial Usage in Danish Pig Production-Evaluating the Effect of the Yellow Card Scheme [J].
Antunes, Ana Carolina Lopes ;
Jensen, Vibeke Frokjaer .
FRONTIERS IN VETERINARY SCIENCE, 2020, 7
[7]   Multidrug resistant Salmonella enterica isolated from conventional pig farms using antimicrobial agents in preventative medicine programmes [J].
Cameron-Veas, Karla ;
Fraile, Lorenzo ;
Napp, Sebastian ;
Garrido, Victoria ;
Jesus Grillo, Maria ;
Migura-Garcia, Lourdes .
VETERINARY JOURNAL, 2018, 234 :36-42
[8]   Assessing the Linkages between Knowledge and Use of Veterinary Antibiotics by Pig Farmers in Rural China [J].
Chen, Xiujuan ;
Wu, Linhai ;
Xie, Xuyan .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2018, 15 (06)
[9]   Strategic measures for the control of surging antimicrobial resistance in Hong Kong and mainland of China [J].
Cheng, Vincent C. C. ;
Wong, Sally C. Y. ;
Ho, Pak-Leung ;
Yuen, Kwok-Yung .
EMERGING MICROBES & INFECTIONS, 2015, 4
[10]   Novel classes of antibiotics or more of the same? [J].
Coates, Anthony R. M. ;
Halls, Gerry ;
Hu, Yanmin .
BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (01) :184-194